Analyst Activity – HC Wainwright Reiterates Buy on Biopharmx Corp (NASDAQ:BPMX)

Analyst Ratings For Biopharmx Corp (NASDAQ:BPMX)

Story continues below

Today, HC Wainwright reiterated its Buy rating on Biopharmx Corp (NASDAQ:BPMX) with a price target of $3.00.

There are 3 buy ratings on the stock.

The current consensus rating on Biopharmx Corp (NASDAQ:BPMX) is Buy (Score: 3.00) with a consensus target price of $2.50 per share, a potential 822.51% upside.

Some recent analyst ratings include

  • 9/19/2017-HC Wainwright Reiterated Rating of Buy.
  • 9/13/2017-Maxim Group Reiterated Rating of Buy .


    Recent Trading Activity for Biopharmx Corp (NASDAQ:BPMX)
    Shares of Biopharmx Corp closed the previous trading session at with shares trading hands.

    An ad to help with our costs